(1)As used in this section:
(1)(a) "Academic research cannabis license" means the license described in Title 4, Chapter 41a, Part 9, Academic Medical Cannabis Research.
(1)(b) "Cannabis" means the same as that term is defined in Section 26B-4-201.
(1)(c) "Cannabis cultivation facility" means the same as that term is defined in Section 4-41a-102.
(1)(d) "Cannabis product" means the same as that term is defined in Section 26B-4-201.
(1)(e) "Center" means the Center for the Medical Cannabis Research created in this section.
(1)(f) "Eligible institution" means an institution of higher education that:
(1)(f)(i) is located in Utah; and
(1)(f)(ii) has or will obtain an academic research cannabis license.
(1)(g) "Medical cannabis patient card" means the same as that term is defined in Section 26B
Free access — add to your briefcase to read the full text and ask questions with AI
(1) As used in this section:
(1)(a) "Academic research cannabis license" means the license described in Title 4, Chapter 41a, Part 9, Academic Medical Cannabis Research.
(1)(b) "Cannabis" means the same as that term is defined in Section 26B-4-201.
(1)(c) "Cannabis cultivation facility" means the same as that term is defined in Section 4-41a-102.
(1)(d) "Cannabis product" means the same as that term is defined in Section 26B-4-201.
(1)(e) "Center" means the Center for the Medical Cannabis Research created in this section.
(1)(f) "Eligible institution" means an institution of higher education that:
(1)(f)(i) is located in Utah; and
(1)(f)(ii) has or will obtain an academic research cannabis license.
(1)(g) "Medical cannabis patient card" means the same as that term is defined in Section 26B-4-201.
(2) There is created the Center for Medical Cannabis Research within the University of Utah.
(3) The center:
(3)(a) shall seek state, federal, and private funds to award grants for medical cannabis research;
(3)(b) shall facilitate and support funding for research related to the health effects, including the potential risks or side effects, of the use of cannabis products;
(3)(c) shall facilitate and support funding for research related to the efficacy and potential health effects of various cannabis delivery methods, including vaporizing, ingesting, topical application, and combustion;
(3)(d) shall support researchers in applying for and securing federal and private research grant funding for expanding medical cannabis research;
(3)(e) shall review current and future cannabis research literature, clinical studies, and clinical trials;
(3)(f) shall educate medical providers, lawmakers, and the public about medical cannabis research advances;
(3)(g) shall, if requested, consult with researchers and eligible institutions seeking to conduct medical cannabis research regarding legal implications of the research under state and federal law;
(3)(h) shall monitor, to the extent that appropriate and sufficient data are available, patient outcomes in any state with a medicinal cannabis program;
(3)(i) may coordinate, share knowledge, and share best practices with a state:
(3)(i)(i) that has a medical cannabis program; and
(3)(i)(ii) is conducting cannabis research;
(3)(j) may award or facilitate funding for grants to an eligible institution for medical cannabis research, including research regarding the growing of a medical-grade cannabis plant that is used for a cannabis product;
(3)(k) shall support a licensed cannabis cultivation facility to provide medical-grade cannabis products for research;
(3)(l) shall make, for research conducted by the center, the research outcomes publicly available;
(3)(m) shall maintain a catalog of all published scientific reports based on projects funded or managed by the center;
(3)(n) shall ensure that an individual who agrees to use a cannabis product as part of a research project conducted by the center or a grantee has:
(3)(n)(i) a valid medical cannabis patient card from the state; or
(3)(n)(ii) if included in the research project as a resident of another state, the equivalent of a medical cannabis patient card under the laws of another state, district, territory, commonwealth, or insular possession of the United States;
(3)(o) shall obtain an academic research cannabis license;
(3)(p) may apply for, or assist an eligible institution to apply for, a federal cannabis cultivation registration to locate a cannabis cultivation site in Utah; and
(3)(q) for the report described in Section 26B-4-222, shall provide information to the Department of Health and Human Services describing:
(3)(q)(i) all research projects that are funded by a grant awarded by the center, including which institution received the grant;
(3)(q)(ii) all research projects conducted by the center; and
(3)(q)(iii) the adequacy of funding for the center's duties.
(4) For research funded, conducted, or facilitated by the center, the center shall ensure the research:
(4)(a) includes appropriate research development, testing, and evaluation; and
(4)(b) if the research involves human subjects, is reviewed, approved, and overseen by an institutional review board as defined in Section 26B-4-212.
(5) The University of Utah shall provide staff for the center.